Emily Hill
2020
In 2020, Emily Hill earned a total compensation of $3.7M as Chief Financial Officer at PTC Therapeutics, a 57% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $312,100 |
|---|---|
| Option Awards | $2,414,167 |
| Salary | $458,333 |
| Stock Awards | $475,788 |
| Other | $12,063 |
| Total | $3,672,451 |
Hill received $2.4M in option awards, accounting for 66% of the total pay in 2020.
Hill also received $312.1K in non-equity incentive plan, $458.3K in salary, $475.8K in stock awards and $12.1K in other compensation.
Rankings
In 2020, Emily Hill's compensation ranked 3,153rd out of 13,090 executives tracked by ExecPay. In other words, Hill earned more than 75.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,153 out of 13,090 | 76th |
Division Manufacturing | 1,229 out of 5,620 | 78th |
Major group Chemicals And Allied Products | 466 out of 2,253 | 79th |
Industry group Drugs | 404 out of 1,953 | 79th |
Industry Pharmaceutical Preparations | 302 out of 1,458 | 79th |
Source: SEC filing on April 29, 2021.
Hill's colleagues
We found five more compensation records of executives who worked with Emily Hill at PTC Therapeutics in 2020.
2020
Stuart Peltz
PTC Therapeutics
Chief Executive Officer
2020
Marcio Souza
PTC Therapeutics
Chief Operating Officer
2020
Eric Pauwels
PTC Therapeutics
Chief Business Officer
2020
Neil Almstead
PTC Therapeutics
Chief Technical Operations Officer
2020
Mark Boulding
PTC Therapeutics